BHB Therapeutics
Developing preventative medicines for age-related disease using ketone bodies
Formed in early 2019 as a collaboration between Juvenescence and the Buck Institute for Research on Aging.
No website as of July 2020.
Details last updated 14-Jul-2020
Mentioned in this Resource
BHB Therapeutics News
Longevity.Technology interviews Buck Institute’s President and CEO Eric Verdin
Longevity Technology - 03-Oct-2019
Includes updates on NAPA Therapeutics and BHB Therapeutics
Read more...Calorie restriction drugs may help you live longer
Fight Aging! - 15-Feb-2019
BHB therapeutics develops treatment to mimic the effects of good diet
Read more...